|
|
Volumn 312, Issue 5772, 2006, Pages 380-382
|
|
A one-size-fits-all flu vaccine?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORE PROTEIN;
DNA VACCINE;
IMMUNOLOGICAL ADJUVANT;
INFLUENZA VACCINE;
INFLUENZA VIRUS HEMAGGLUTININ;
LIVE VACCINE;
M2 PROTEIN, INFLUENZA A VIRUS;
MATRIX PROTEIN;
NP PROTEIN, INFLUENZA A VIRUS;
NUCLEOPROTEIN;
RNA BINDING PROTEIN;
VIRUS ANTIBODY;
ANIMAL;
ANTIGENIC VARIATION;
ARTICLE;
BIOSYNTHESIS;
CLINICAL TRIAL;
CYTOTOXIC T LYMPHOCYTE;
DRUG SCREENING;
GENETICS;
HUMAN;
IMMUNOLOGY;
INFLUENZA;
INFLUENZA VIRUS A;
INTRANASAL DRUG ADMINISTRATION;
MOUSE;
ORTHOMYXOVIRUS INFECTION;
VACCINATION;
ADJUVANTS, IMMUNOLOGIC;
ADMINISTRATION, INTRANASAL;
ANIMALS;
ANTIBODIES, VIRAL;
ANTIGENIC VARIATION;
CLINICAL TRIALS;
DRUG EVALUATION, PRECLINICAL;
HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS;
HUMANS;
INFLUENZA A VIRUS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
MICE;
NUCLEOPROTEINS;
ORTHOMYXOVIRIDAE INFECTIONS;
RNA-BINDING PROTEINS;
T-LYMPHOCYTES, CYTOTOXIC;
VACCINATION;
VACCINES, ATTENUATED;
VACCINES, DNA;
VIRAL CORE PROTEINS;
VIRAL MATRIX PROTEINS;
|
|
EID: 33646130842
PISSN: None
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.312.5772.380 Document Type: Article |
|
Times cited : (49)
|
|
References (0)
|
